About Kedrion
Kedrion is a company based in Barga (Italy) founded in 2001 was acquired by Permira in January 2022.. Kedrion has raised $188.56 million across 2 funding rounds from investors including Permira, CDP Equity and IMI Fondi Chiusi SGR. Kedrion operates in a competitive market with competitors including Moderna, CareDx, Forge Biologics, Editas Medicine and Annexon, among others.
- Headquarter Barga, Italy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kedrion Biopharma India Private Limited
- Date of Incorporation 06 Dec, 2013
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$4.32 M (USD)17.9as on Mar 31, 2020
-
Net Profit
$-957.81 K (USD)-143.53as on Mar 31, 2020
-
EBITDA
$-1.61 M (USD)-79.73as on Mar 31, 2020
-
Total Equity Funding
$188.56 M (USD)
in 2 rounds
-
Latest Funding Round
$188.56 M (USD), Series E
Jul 05, 2012
-
Investors
Permira
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Permira
(Jan 20, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
55 people
Leadership Team
29 people
Human Resources and Administration
14 people
Sales and Marketing
13 people
Senior Team
9 people
Legal and Compliance
9 people
Operations Team
9 people
Product Management Team
8 people
Unlock access to complete
Funding Insights of Kedrion
Kedrion has successfully raised a total of $188.56M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $188.56 million completed in July 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series E — $188.6M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2012 | Amount | Series E - Kedrion | Valuation | CDP Equity |
|
| Jun, 2003 | Amount | Seed - Kedrion | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kedrion
Kedrion has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Permira, CDP Equity and IMI Fondi Chiusi SGR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on buyouts
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kedrion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kedrion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kedrion Comparisons
Competitors of Kedrion
Kedrion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, CareDx, Forge Biologics, Editas Medicine and Annexon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Medical solutions for transplant patients are developed and provided.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic diseases are developed using CRISPR technology.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for autoimmune diseases are developed by the company.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kedrion
Frequently Asked Questions about Kedrion
When was Kedrion founded?
Kedrion was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Where is Kedrion located?
Kedrion is headquartered in Barga, Italy. It is registered at Barga, Tuscany, Italy.
Is Kedrion a funded company?
Kedrion is a funded company, having raised a total of $188.56M across 2 funding rounds to date.
What is the annual revenue of Kedrion?
Annual revenue of Kedrion is $4.32M as on Mar 31, 2020.
What does Kedrion do?
Founded in 2001 and headquartered in Barga, Italy, Kedrion operates in the biotechnology sector. Blood plasma is collected and fractionated to produce therapies addressing hemophilia, immune system deficiencies, and critical care needs, including Albumin and Anti-D Immunoglobulin (RhoGAM) for preventing hemolytic disease in newborns. Efforts are focused on expanding the pipeline in hematology, immunology, and critical care areas.
Who are the top competitors of Kedrion?
Who are Kedrion's investors?
Kedrion has 4 investors. Key investors include Permira, CDP Equity, IMI Fondi Chiusi SGR, and Marcucci family.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.